Martha E. Linsenmeyer
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
Papers in
-
- Epigenetics and DNA Methylation 3
- Cancer therapeutics and mechanisms 2
- Cancer-related gene regulation 2
- Advanced biosensing and bioanalysis techniques 2
- Oncology 3
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- D.M. Woodcock (12 shared papers)J.P. Doherty (5 shared papers)William Warren (3 shared papers)P.J. Crowther (4 shared papers)Michael Millward (4 shared papers)Lorraine K. Webster (3 shared papers)James F. Bishop (3 shared papers)B T Williams (1 shared paper)
In The Last Decade
Martha E. Linsenmeyer
13 papers receiving 561 citations
Peers
Comparison fields: 5 of 73
- Oncology 256
- Pharmaceutical Science 28
- Biomaterials 57
- Pharmacology 34
- Molecular Biology 269
Countries citing papers authored by Martha E. Linsenmeyer
This map shows the geographic impact of Martha E. Linsenmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha E. Linsenmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha E. Linsenmeyer more than expected).
Fields of papers citing papers by Martha E. Linsenmeyer
This network shows the impact of papers produced by Martha E. Linsenmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha E. Linsenmeyer. The network helps show where Martha E. Linsenmeyer may publish in the future.
Co-authors
The 24 scholars most cited alongside Martha E. Linsenmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. | 1990 | 157 |
| 2 | 1997 | 128 | |
| 3 | 1993 | 124 | |
| 4 | 1991 | 37 | |
| 5 | 1997 | 32 | |
| 6 | 1998 | 32 | |
| 7 | Phase I trial of cremophor EL with bolus doxorubicin. | 1998 | 30 |
| 8 | 2002 | 13 | |
| 9 | 1998 | 11 | |
| 10 | 1991 | 9 | |
| 11 | 1994 | 6 | |
| 12 | 1994 | 2 | |
| 13 | 1991 | 2 |
About Martha E. Linsenmeyer
Martha E. Linsenmeyer is a scholar working on Molecular Biology, Oncology, Genetics, Ecology and Epidemiology, having authored 13 papers that have together received 583 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Genetics and Neurodevelopmental Disorders (2 papers), Chromosomal and Genetic Variations (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer-related gene regulation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Oncology (256 citations), Pharmaceutical Science (28 citations), Biomaterials (57 citations), Pharmacology (34 citations) and Molecular Biology (269 citations). Martha E. Linsenmeyer has collaborated with scholars based in Australia and Germany. Frequent co-authors include D.M. Woodcock, J.P. Doherty, William Warren, P.J. Crowther, Michael Millward, Lorraine K. Webster, James F. Bishop, B T Williams, Ivan Bertoncello and Grace Chojnowski. Their work appears in journals such as Gene, Journal of Biological Chemistry, Anti-Cancer Drugs, JNCI Journal of the National Cancer Institute and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.